Operator: Good day and thank you for standing by. Welcome to the LumiraDx First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Operator: Good day and thank you for standing by. Welcome to the LumiraDx Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
LONDON, June 8, 2022 /PRNewswire/ LumiraDx Limited (Nasdaq: LMDX) today announced that it has achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2
Strong Growth in Instruments Delivered to Customers and Continued Innovation on our Platform LONDON, May 11, 2022 /PRNewswire/ LumiraDx Limited (Nasdaq: LMDX), a next-generation point
/PRNewswire/ LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial and operational results.